{"name":"Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno","slug":"centro-de-educaci-n-medica-e-investigaciones-cl-nicas-norberto-quirno","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Bivalent RBD-based ARVAC-CG vaccine","genericName":"Bivalent RBD-based ARVAC-CG vaccine","slug":"bivalent-rbd-based-arvac-cg-vaccine","indication":"COVID-19","status":"phase_2"},{"name":"COVID19 convalescent plasma infusion","genericName":"COVID19 convalescent plasma infusion","slug":"covid19-convalescent-plasma-infusion","indication":"COVID-19 (severe or life-threatening disease)","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"High-Dose Dexamethasone","genericName":"High-Dose Dexamethasone","slug":"high-dose-dexamethasone","indication":"Acute inflammatory conditions","status":"marketed"}]}],"pipeline":[{"name":"Bivalent RBD-based ARVAC-CG vaccine","genericName":"Bivalent RBD-based ARVAC-CG vaccine","slug":"bivalent-rbd-based-arvac-cg-vaccine","phase":"phase_2","mechanism":"ARVAC-CG vaccine targets the RBD of SARS-CoV-2","indications":["COVID-19"],"catalyst":""},{"name":"COVID19 convalescent plasma infusion","genericName":"COVID19 convalescent plasma infusion","slug":"covid19-convalescent-plasma-infusion","phase":"phase_3","mechanism":"COVID-19 convalescent plasma infusion transfers antibodies and immune factors from recovered patients to provide passive immunotherapy against SARS-CoV-2.","indications":["COVID-19 (severe or life-threatening disease)","COVID-19 (hospitalized patients)"],"catalyst":""},{"name":"High-Dose Dexamethasone","genericName":"High-Dose Dexamethasone","slug":"high-dose-dexamethasone","phase":"marketed","mechanism":"High-dose dexamethasone is a potent synthetic glucocorticoid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.","indications":["Acute inflammatory conditions","Autoimmune disorders","Cerebral edema","Severe allergic reactions","Adrenal insufficiency"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":1,"phase_3":1,"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}